Single award · contract

Objective of This Task Order Supports Niaids Goal to Conduct a Series of Standardized Phase 1 and Phase 2…

Award ID: 75N91023F00008

FY2023 · complete year · data as of 2026-07-03

A single federal award, with both ends of the trail linked.

$173.3M
Total award value

Award 75N91023F00008 is a contract from the Department of Health and Human Services to Leidos Biomedical Research Inc, $173.3M obligated, FY2023 to FY2029, for Objective of This Task Order Supports Niaids Goal to Conduct a Series of Standardized Phase 1 and…. The work is performed in Maryland. It is classified as NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)) and PSC AN12 (Health R&D Services; Health Care Services; Applied Research). Source

Description

The Objective of This Task Order Supports Niaids Goal to Conduct a Series of Standardized Phase 1 and Phase 2 Trials on Next-Generation Vaccines to Generate Data to Inform Decisions on Which Candidates to Support for Advanced Development.

Award details

Award typeContract
PIID75N91023F00008
Action date2023
Period72 mo
Place of performanceMaryland →
Competed?Not recordedSource
Total (exact)$173,281,267

More awards to Leidos Biomedical Research Inc

awarded 2019$432.4M

More from Department of Health and Human Services

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.